Market Place
Sourcing Support
OSR Holdings Clears $2.02M Warrant Overhang Via Convertible Note
09 Apr 2026 //
PHARMIWEB
OSR Holdings Updates Investors at EGC on April 15, 2023
30 Mar 2026 //
PHARMIWEB
Emerging Growth Reaffirms Buy on OSR Holdings
27 Mar 2026 //
PHARMIWEB
OSR Holdings Updates $815M VXM01 Deal to Boost Parent Value
23 Mar 2026 //
PHARMIWEB
OSR`s Woori IO Inks NDA with Sinopharm for China Deal
19 Mar 2026 //
PHARMIWEB
OSR Holdings Granted 180-Day Nasdaq Extension
05 Mar 2026 //
PHARMIWEB
Vaximm AG Revises Term Sheet to Shorten BCM Europe Exclusivity
02 Dec 2025 //
PR NEWSWIRE
OSR Holdings Presents at Emerging Growth Conference, Dec. 10
01 Dec 2025 //
PR NEWSWIRE
Vaximm AG Enters Term With BCM Europe for VXM01 License
21 Nov 2025 //
PR NEWSWIRE
OSR Holdings Names Dr. Andreas Niethammer of CEO Of Vaximm AG
14 Nov 2025 //
PR NEWSWIRE
OSR Holdings Acquires Woori IO, Advancing Glucose Monitoring
14 Oct 2025 //
PR NEWSWIRE
OSR Holdings Gets Nasdaq Notice on Trading Issues
10 Sep 2025 //
PR NEWSWIRE
OSR Holdings to Acquire Noninvasive Glucose Tech Pioneer Woori IO
24 Jul 2025 //
PR NEWSWIRE
OSR Holdings Names Andreas as Vaximm AG`s Chief Medical Officer
15 Jul 2025 //
PR NEWSWIRE
Darnatein, OSR Company, Expands IP Protection for Arthritis Tech
09 Apr 2025 //
PR NEWSWIRE
Vaximm AG Announces Phase 2a Trial Results for Glioblastoma
26 Mar 2025 //
PR NEWSWIRE
OSR, SillaJen MOU For US Therapeutic Development
22 Apr 2024 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.